ECO Animal Health (AIM:EAH) – tremendous results but a pity about the inventory build
The developer of pharmaceutical products for animals has delivered outstanding interim results for the 6 months ending 30th September. With the second half of the year also starting well and cash building this business looks in great shape, although the valuation now appears to factor in quite a lot of good news!
ECO Animal Health delivers products to promote animal well-being and sustainable productivity. The company now holds over 600 marketing authorisations, in over 50 countries, and has developed strong relationships with a number of distribution partners globally. The Group’s proprietary Aivlosin® product contains the innovative antibiotic tylvalosin, which is rapidly absorbed and concentrates in target tissues to provide proven treatment of major respiratory and enteric diseases in both pigs and poultry. Generic drugs include Ecomectin®, Ecoheart, Ecotraz & Ecomintic (endectocides & other antiparasitics) for the treatment and prevention of parasites in cattle, sheep, pigs, horses and dogs. Chlortet & Oxytet cover…